Showing results (31-40 of 45) with videos related to

Sort By:
Pageof 5
Nature Communications|January 21, 2024
Activating p53 abolishes self-renewal of quiescent leukaemic stem cells in residual CML diseaseMary T Scott, Wei Liu, Rebecca Mitchell, et al.
Genome Research|September 12, 2006
Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sitesGeorge A Follows, Pawan Dhami, Berthold Göttgens, et al.
Molecular and Biochemical Parasitology|May 13, 2004
Expression profiling of the Leishmania life cycle: cDNA arrays identify developmentally regulated genes present but not annotated in the genomeRenata Almeida, Brian J Gilmartin, Sharon H McCann, et al.
The Journal of Clinical Investigation|April 14, 2009
Targeting autophagy potentiates tyrosine kinase inhibitor-induced cell death in Philadelphia chromosome-positive cells, including primary CML stem cellsCristian Bellodi, Maria Rosa Lidonnici, Ashley Hamilton, et al.
Cancer Discovery|September 16, 2016
Epigenetic Reprogramming Sensitizes CML Stem Cells to Combined EZH2 and Tyrosine Kinase InhibitionMary T Scott, Koorosh Korfi, Peter Saffrey, et al.
Science (New York, N.Y.)|April 28, 2007
Requirement of bic/microRNA-155 for normal immune functionAntony Rodriguez, Elena Vigorito, Simon Clare, et al.
Plos One|September 3, 2010
Complex exon-intron marking by histone modifications is not determined solely by nucleosome distributionPawandeep Dhami, Peter Saffrey, Alexander W Bruce, et al.
Human Mutation|November 16, 2005
Identification of genetic aberrations on chromosome 22 outside the NF2 locus in schwannomatosis and neurofibromatosis type 2Patrick G Buckley, Kiran K Mantripragada, Teresita Díaz de Ståhl, et al.
Nature|June 10, 2016
Dual targeting of p53 and c-MYC selectively eliminates leukaemic stem cellsSheela A Abraham, Lisa E M Hopcroft, Emma Carrick, et al.
Pageof 5